Manufacturing, Gene Therapies

The Benefit of Long-Read Sequencing in Gene Therapies

June 18, 2024

Nadia Sellami, PhD, global segment lead for gene and cell therapy at PacBio, talks about long-read sequencing for cell and gene editing in a video interview.

The Need for Automated and Standardized CGT Manufacturing (BIO 2024)

June 07, 2024

Lonza’s Joe Garrity and Jerry Jiang discuss the importance of not only automating CGT manufacturing, but also standardizing across processes.

Trends and Obstacles in the CGT Field (BIO 2024)

June 07, 2024

Lonza’s Joe Garrity and Jerry Jiang discuss the latest trends and challenges in commercializing new CGTs.

CGT Catapult and CATTI Establish Shared Training Standards for Advanced Therapies

June 04, 2024

CGT Catapult and CATTI aim to standardize advanced therapy manufacturing with new aligned training standards.

Seeking Excellence with CRISPR (BIO 2024)

June 04, 2024

Pharm Tech Group chats with Dr. Monika Paulė, CEO and co-founder of Caszyme about the evolution of CRISPR.

CGT Catapult and Cellular Origins Team Up to Develop Automated CGT Manufacturing

June 01, 2024

CGT Catapult will implement Cellular Origins' robotic platform in its Stevenage, UK, site to establish automated CGT manufacturing.

Merck KGaA Announces $600 Million Deal to Acquire Mirus Bio

May 24, 2024

With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.

Research Shows that HIC Can Effectively Separate Deaminated Capsids from Non-Deaminated Capsids (ASGCT 2024)

May 11, 2024

The separation of deamidated capsids from non-deamidated capsids can be achieved using HIC, according to studies done by a team at Oxford Biomedica.

ASGCT 2024: Additives Play a Role in Removal of Empty and Partial AAV Capsids

May 08, 2024

Experiments conducted by the downstream technology team at Spark Therapeutics involving metal ion-containing additives showed improved capsid clearance in AAV production.

New Cell Factory Box Launched by ProPharma and PBL for Automated CGT Manufacturing

May 07, 2024

ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.